[CIS PIDD] [cis-pidd] pneumococcal vaccine strategy in adolescents & adults with immune deficiency
Pata
patar20000 at yahoo.es
Thu Dec 5 15:45:25 EST 2013
And what si the reason to wait one year in adults?
Patricia Roessler
Clinical Immunologyst
Chile
Enviado desde mi iPhone
El 12/05/2013, a las 17:19, "Boyce, Thomas G., M.D." <Boyce.Thomas at mayo.edu> escribió:
> This is true in adults. In children, you only need to wait 2 months.
>
> From: bounce-44205117-183824398 at lists.clinimmsoc.org [mailto:bounce-44205117-183824398 at lists.clinimmsoc.org] On Behalf Of Stan Ress
> Sent: Thursday, December 05, 2013 2:11 PM
> To: CIS-PIDD
> Subject: RE: [cis-pidd] pneumococcal vaccine strategy in adolescents & adults with immune deficiency
>
> Hi Laia,
>
> I’d really like to hear what others think but what I understood from the ACIP statement is that, after PPSV23 vaccination, you need to wait at least one year before giving the 13-valent conjugate vaccine (Prevenar 13).
>
> Regards,
>
> Stan
>
> --
> Stanley Ress
> Associate Professor of Medicine
> Head: Division of Clinical Immunology
> Department of Medicine
> H47 Old Main Building-room 26
> Groote Schuur Hospital and UCT
> Observatory 7925
> Cape Town
> South Africa
> TEL:INTERN. + 2721-4066201 or 4066197
> FAX: " + 2721-(0)865173095
> Cell: 0833115482
> email: stan.ress at uct.ac.za
>
>
> From: Laia Alsina Manrique de Lara [mailto:lalsina at hsjdbcn.org]
> Sent: 05 December 2013 09:29 PM
> To: CIS-PIDD
> Cc: CIS-PIDD
> Subject: Re: [cis-pidd] pneumococcal vaccine strategy in adolescents & adults with immune deficiency
>
> OK,
> So how bad would it be to administer first Pneumovax23 to complete diagnosis, and if no response is observed, administer Prevenar13 for prophylactic purposes +/- IGRT?
>
> Laia Alsina
> Allergy and Clinical Immunology Department,
> Hospital Sant Joan de Deu, Barcelona.
>
> El 04/12/2013, a las 21:13, "John Ziegler" <j.ziegler at unsw.edu.au> escribió:
>
> Stan
>
> PPV23 as primary vaccine is still popular in this setting among my colleagues but I think it's unethical not to give PCV13 first.
>
> John
>
>
> _________________________
> Professor John B. Ziegler, AM
> Department of Immunology & Infectious Diseases
> Sydney Children's Hospital
> High St., Randwick NSW 2031
> Australia
> T: (02) 93821515
> F: + 61 + 2 93821580
> E: j.ziegler at unsw.edu.au
>
> On 5 Dec 2013, at 8:06 am, "Stan Ress" <stan.ress at uct.ac.za> wrote:
>
> Hi all,
>
> I have been referred a 15 year-old patient with extremely severe IgA deficiency, recurrent respiratory infections, & bronchiectasis on CT chest. Her baseline vaccine status revealed low IgG ELIZA antibodies against 4/5 antigens, including S. pneumonia & H. Influenza B. Our policy has been to vaccinate such patients with 23-valent pneumococcal polysaccharide vaccine. However, I saw a reference to ACIP recommendation that children & adults with immune compromising conditions or asplenia, should receive 13-valent conjugate vaccine 1st, followed 8 weeks later by unconjugated PPSV23.
>
> Is this the general current practise?
>
> Thanks.
> --
> Stanley Ress
> Associate Professor of Medicine
> Head: Division of Clinical Immunology
> Department of Medicine
> H47 Old Main Building-room 26
> Groote Schuur Hospital and UCT
> Observatory 7925
> Cape Town
> South Africa
> TEL:INTERN. + 2721-4066201 or 4066197
> FAX: " + 2721-(0)865173095
> Cell: 0833115482
> email: stan.ress at uct.ac.za
>
> UNIVERSITY OF CAPE TOWN
>
> This e-mail is subject to the UCT ICT policies and e-mail disclaimer published on our website at http://www.uct.ac.za/about/policies/emaildisclaimer/ or obtainable from +27 21 650 9111. This e-mail is intended only for the person(s) to whom it is addressed. If the e-mail has reached you in error, please notify the author. If you are not the intended recipient of the e-mail you may not use, disclose, copy, redirect or print the content. If this e-mail is not related to the business of UCT it is sent by the sender in the sender's individual capacity.
> ---
>
> The CIS-PIDD listserv is supported by:
>
> <image001.jpg>
> The science & practice of human immunology
>
> P: +1.414.224.8095
> E: info at clinimmsoc.org
>
> Not a member of CIS? Please visit www.clinimmsoc.org to join!
>
> You are currently subscribed to cis-pidd as: j.ziegler at unsw.edu.au.
> To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183824805.15fcb3e73d1784a002f4bfafdad280c5&n=T&l=cis-pidd&o=44201035
>
> ---
>
> The CIS-PIDD listserv is supported by:
>
> <image001.jpg>
> The science & practice of human immunology
>
> P: +1.414.224.8095
> E: info at clinimmsoc.org
>
> Not a member of CIS? Please visit www.clinimmsoc.org to join!
>
> You are currently subscribed to cis-pidd as: lalsina at hsjdbcn.org.
> To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183824379.b100fe2a38d513f306e01a50580e257e&n=T&l=cis-pidd&o=44201076
>
>
> No imprimir aquest correu ajudarà a preservar el medi ambient.
> Si vostè no és el destinatari del missatge, o l'ha rebut per error, si us plau notifiqui-ho al remitent i destrueixi el missatge amb tot el seu contingut. Està prohibida la distribució no autoritzada del contingut d'aquest missatge.
>
> No imprimir este correo ayudará a preservar el medio ambiente.
> Si usted no es el destinatario del mensaje, o lo ha recibido por error, notifíquelo por favor al remitente y destruya el mensaje con todo su contenido. Está prohibida la distribución no autorizada del contenido de este mensaje.
> ---
>
> The CIS-PIDD listserv is supported by:
>
> <image001.jpg>
> The science & practice of human immunology
>
> P: +1.414.224.8095
> E: info at clinimmsoc.org
>
> Not a member of CIS? Please visit www.clinimmsoc.org to join!
>
> You are currently subscribed to cis-pidd as: stan.ress at uct.ac.za.
> To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183824729.985c4c1fc1b701ae5f23bbbaa7fc60d8&n=T&l=cis-pidd&o=44204966
>
>
> ---
>
> The CIS-PIDD listserv is supported by:
>
> <image001.jpg>
> The science & practice of human immunology
>
> P: +1.414.224.8095
> E: info at clinimmsoc.org
>
> Not a member of CIS? Please visit www.clinimmsoc.org to join!
>
> You are currently subscribed to cis-pidd as: stan.ress at uct.ac.za.
> To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183824729.985c4c1fc1b701ae5f23bbbaa7fc60d8&n=T&l=cis-pidd&o=44204966
>
> ---
>
> The CIS-PIDD listserv is supported by:
>
>
> The science & practice of human immunology
>
> P: +1.414.224.8095
> E: info at clinimmsoc.org
>
> Not a member of CIS? Please visit www.clinimmsoc.org to join!
>
> You are currently subscribed to cis-pidd as: boyce.thomas at mayo.edu.
> To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183824398.f2b8412bd8ff7bcbcdffccce20d02a5f&n=T&l=cis-pidd&o=44205117
>
> ---
>
> The CIS-PIDD listserv is supported by:
>
>
> The science & practice of human immunology
>
> P: +1.414.224.8095
> E: info at clinimmsoc.org
>
> Not a member of CIS? Please visit www.clinimmsoc.org to join!
>
> You are currently subscribed to cis-pidd as: patar20000 at yahoo.es.
> To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183824736.0ff4cb0c77623023962d3c4ffeaaa470&n=T&l=cis-pidd&o=44205149
---
The CIS-PIDD listserv is supported by the Clinical Immunology Society
The science & practice of human immunology
P: +1.414.224.8095
E: info at clinimmsoc.org
Not a member of CIS? Please visit www.clinimmsoc.org to join!
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183939985.3ea13d40a15475ac00ebbd9cd8a37d6d&n=T&l=cis-pidd&o=44205185
or send a blank email to leave-44205185-183939985.3ea13d40a15475ac00ebbd9cd8a37d6d at lists.clinimmsoc.org
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://seven.pairlist.net/pipermail/pagid/attachments/20131205/475d073b/attachment.html>
More information about the PAGID
mailing list